deltacortene: Clinical Trials

10 trials of deltacortene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 10
Phase 21Completed 1

Follow deltacortene: new trials by email Literature Review of deltacortene trials Research Report on deltacortene

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Clofarabine, Cyclophosphamide, Cytarabine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
Phase 3CompletedNational Cancer Institute (NCI)59492012-02-292026-06-02
Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Calaspargase Pegol-mknl, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia
Phase 3CompletedChildren's Oncology Group1662008-07-212021-04-27
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Asparaginase, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 2 / Phase 3CompletedNational Cancer Institute (NCI)632008-07-142020-04-13
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Asparaginase, Biospecimen Collection, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia
Phase 3CompletedChildren's Oncology Group2182008-01-152024-07-15
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Asparaginase, Cyclophosphamide, Cytarabine - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Phase 3CompletedNational Cancer Institute (NCI)18952007-01-302026-06-23
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
Phase 3CompletedChildren's Oncology Group532004-03-152023-04-18
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia
Phase 3CompletedChildren's Oncology Group31542003-12-292021-04-27
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
Bleomycin Sulfate, Cisplatin, Cyclophosphamide - Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma, Childhood Mixed Cellularity Classical Hodgkin Lymphoma
Phase 3CompletedChildren's Oncology Group17342002-09-012017-04-12
Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma
Bleomycin, Etoposide, Doxorubicin - Hodgkin Lymphoma
Phase 3CompletedFondazione Michelangelo3312000-03-012015-08-13
Steroids and Azathioprine in Advanced IgAN
methylprednisolone, azathioprine, prednisone - IgA Nephropathy, Chronic Kidney Disease
Phase 3CompletedA. Manzoni Hospital461999-12-012011-07-13

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Burkitt Lymphoma (3)  ·  Hodgkin Disease (2)  ·  Glomerulonephritis, IGA (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Neuroblastoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Proteinuria (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Children's Oncology Group (5)  ·  National Cancer Institute (NCI) (3)  ·  A. Manzoni Hospital (1)  ·  Fondazione Michelangelo (1)

Countries

United States (8)  ·  Australia (7)  ·  Canada (7)  ·  New Zealand (6)  ·  Switzerland (4)  ·  Puerto Rico (3)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Alessandro M Gianni, MD (1)  ·  Anne L Angiolillo (1)  ·  Debra Friedman (1)  ·  Eric C Larsen (1)  ·  Joanne M Hilden (1)  ·  Michael J Burke (1)  ·  Pedro A De Alarcon (1)  ·  Stuart S Winter (1)  ·  William B Slayton (1)

Results publications

PMID 37890117, PMID 39121442, PMID 42085640, PMID 21774708, PMID 24970932, PMID 25311218, PMID 26124497, PMID 26265699, PMID 26590194, PMID 29284596, PMID 29296710, PMID 29376112, PMID 29812996, PMID 30138085, PMID 30626253, PMID 32414848, PMID 32496902, PMID 32552472, PMID 32813610, PMID 33242441, PMID 33496745, PMID 33512412, PMID 34302711, PMID 34662378, PMID 36603187, PMID 37505794, PMID 37556734, PMID 38446568, PMID 40135712, PMID 40533067, PMID 41592282

NIH funding

U10CA098543 (8), U10CA180886 (4), U10CA013539 (1)